Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OMDA
OMDA logo

OMDA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
16.660
Open
16.480
VWAP
15.32
Vol
3.23M
Mkt Cap
880.53M
Low
14.485
Amount
49.54M
EV/EBITDA(TTM)
140.14
Total Shares
59.42M
EV
668.77M
EV/OCF(TTM)
29.68
P/S(TTM)
3.11
Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
Show More

Events Timeline

(ET)
2026-05-07
16:50:00
Omada Health Reports Q1 Revenue of $78.05M
select
2026-04-17 (ET)
2026-04-17
09:10:00
Omada Health Study Shows GLP-1 Members Achieve Significant Weight Loss
select

News

seekingalpha
9.5
05-08seekingalpha
Omada Health Reports Milestone Q1 2026 Earnings with Strong Growth
  • Significant Revenue Growth: Omada Health reported Q1 2026 revenue of $78 million, a 42% year-over-year increase, surpassing analyst estimates of $74.09 million, indicating strong market performance and growth potential.
  • Membership Milestone: The total membership reached 1,025,000 in Q1, reflecting a 51% year-over-year growth, marking a crucial milestone in expanding the customer base and enhancing market competitiveness.
  • Improved Profitability: The company achieved an adjusted EBITDA of $1 million in Q1, with GAAP net loss narrowing to $3 million, demonstrating positive progress in cost control and profitability, especially during its historically most cost-intensive quarter.
  • Optimistic Outlook: Omada raised its full-year revenue guidance to $322 million to $330 million, with adjusted EBITDA expectations of $14 million to $20 million, reflecting management's confidence in future growth, particularly in promoting GLP-1 prescribing capabilities.
Newsfilter
8.5
04-17Newsfilter
Omada Health Study Shows Significant Weight Loss with GLP-1 Therapy
  • Significant Weight Loss: A study by Omada Health reveals that members in the GLP-1 Care Track lost an average of 6.0% of their body weight, 1.8 times more than the 3.3% loss in the control group, highlighting the program's effectiveness in promoting substantial weight loss.
  • Body Composition Improvements: Participants in the Omada program reduced their body fat percentage by 3.3%, double that of the control group, while increasing muscle mass by nearly three times, demonstrating the program's success in enhancing body composition.
  • Mental Health Benefits: The study also indicated that Omada members reported significant improvements in mental health, physical functioning, and confidence in their weight loss efforts, suggesting that the program addresses overall well-being, not just weight metrics.
  • Long-term Clinical Impact: Omada Health's president emphasized that the success of GLP-1 companion programs should focus on high-quality weight loss, which is crucial for long-term health outcomes and the return on investment potential of GLP-1 treatments.
Newsfilter
9.5
04-16Newsfilter
Omada Health to Release Q1 2026 Results on May 7
  • Earnings Release Schedule: Omada Health will announce its Q1 2026 results on May 7, 2026, after market close, and will host a conference call at 4:30 PM ET the same day to provide detailed insights into its financial performance and future outlook.
  • Conference Call Details: The call will feature a live audio webcast available online, with a replay accessible for approximately 12 months post-call, ensuring that investors who cannot attend live can still access critical information.
  • Company Background: Omada Health focuses on innovating healthcare delivery in the U.S., aiming to improve chronic disease management during the intervals between doctor visits by utilizing a virtual-first model that combines human-led care teams, connected devices, and AI technology to provide personalized support to over two million members.
  • Market Impact Analysis: Omada Health's approach not only addresses gaps in traditional healthcare systems but also enhances its competitive edge in chronic disease management through innovative services like GLP-1 therapy support, which is expected to attract more partnerships with employers and health plans.
seekingalpha
6.0
04-14seekingalpha
Omada Health Receives Market Outperform Rating from Citizens
  • Market Coverage Rating: Citizens initiated coverage on Omada Health (OMDA) with a Market Outperform rating and an $18 price target, highlighting the compelling risk-reward profile of the virtual care provider.
  • Customer Relationship Expansion: Analyst Constantine Davides noted that Omada's market reach has surpassed 2,000 customer relationships, showcasing its diversified platform advantages in weight loss and diabetes, thereby enhancing its competitive position.
  • Valuation Analysis: Since its IPO in 2025, Omada has traded at an average EV/NTM revenue multiple of 3.5x, while currently trading at 1.7x based on Citizens' 2026 revenue estimates, indicating significant undervaluation potential.
  • Optimistic Growth Outlook: Davides projects that OMDA's membership could exceed 1 million in 2025, with revenue and EBITDA CAGR estimates of 16% and 44% over the next four years, suggesting ample runway for sustained double-digit growth in the coming years.
NASDAQ.COM
8.5
03-14NASDAQ.COM
Omada Health's Digital Platform Grows 53% in 2025
  • Significant Sales Growth: Omada Health achieved a 53% increase in sales in 2025, demonstrating the effectiveness of its digital healthcare platform in improving health outcomes for patients with chronic conditions, particularly those on GLP-1 medications.
  • Huge Market Potential: Despite reaching an $800 million market cap, Omada trades at only three times its sales, indicating that its stock is undervalued and has multibagger potential, which could yield substantial returns for investors.
  • Increased User Engagement: The company's mobile app has surpassed 40,000 monthly global downloads, quickly becoming the number one app in its healthcare niche, reflecting its growing popularity and market penetration among users.
  • Improved Profitability: Omada's profit margins rose from -16% to 6% in the fourth quarter, indicating that the company is not only growing sales but also enhancing its profitability, which strengthens its financial stability for the future.
Fool
8.5
03-14Fool
Omada Health: Promising Prospects for Digital Healthcare Startup
  • Significant Market Potential: Launched in 2025, Omada Health has an $800 million market cap; despite a lackluster stock performance, its digital healthcare platform provides crucial guidance for chronic disease patients, showcasing potential as a multibagger.
  • High User Engagement: Omada's mobile app has surpassed 40,000 monthly downloads, quickly becoming the top app in its healthcare niche, with a customer satisfaction rate of 90%, indicating strong appeal and demand in the market.
  • Notable Health Outcomes: Members using GLP-1 have documented 28% more weight loss compared to non-users, and those who stopped GLP-1 but continued with Omada regained only 1% of their body weight after a year, demonstrating the effectiveness of Omada's interventions in improving health outcomes.
  • Strong Financial Performance: In 2025, Omada's sales grew by 53%, with profit margins rising from -16% to 6% in Q4, while trading at just 3 times sales, highlighting its attractiveness as a growth stock and investment opportunity.
Wall Street analysts forecast OMDA stock price to rise
9 Analyst Rating
Wall Street analysts forecast OMDA stock price to rise
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
17.00
Averages
27.00
High
32.00
Current: 0.000
sliders
Low
17.00
Averages
27.00
High
32.00
Goldman Sachs
David Roman
Buy
maintain
$23 -> $26
AI Analysis
2026-05-08
New
Reason
Goldman Sachs
David Roman
Price Target
$23 -> $26
AI Analysis
2026-05-08
New
maintain
Buy
Reason
Goldman Sachs analyst David Roman raised the firm's price target on Omada Health to $26 from $23 and keeps a Buy rating on the shares.
Canaccord
Buy
maintain
$22 -> $24
2026-05-08
New
Reason
Canaccord
Price Target
$22 -> $24
2026-05-08
New
maintain
Buy
Reason
Canaccord raised the firm's price target on Omada Health to $24 from $22 and keeps a Buy rating on the shares. The firm said Omada posted a "milestone" quarter with enrolled members rising 51% and crossing one million while topping firm estimate by 4%.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OMDA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Omada Health Inc (OMDA.O) is 0.00, compared to its 5-year average forward P/E of -528.66. For a more detailed relative valuation and DCF analysis to assess Omada Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-528.66
Current PE
0.00
Overvalued PE
307.73
Undervalued PE
-1365.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
155.80
Current EV/EBITDA
32.67
Overvalued EV/EBITDA
604.12
Undervalued EV/EBITDA
-292.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.33
Current PS
2.54
Overvalued PS
4.59
Undervalued PS
2.06

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is the next 10 bagger?
Intellectia · 76 candidates
Market Cap: <= 5.00BRevenue Ttm: >= 50.00MQuarter Revenue Yoy Growth: >= 15.0%Market Cap Category: small, midQuarter Eps Yoy Growth: >= 15.0%Gross Margin: >= 25.00Relative Vol: >= 1.20Moving Average Relationship: PriceAboveMA20, PriceAboveMA200
Ticker
Name
Market Cap$
top bottom
UROY logo
UROY
Uranium Royalty Corp
602.50M
HRZN logo
HRZN
Horizon Technology Finance Corp
312.64M
NUVB logo
NUVB
Nuvation Bio Inc
1.75B
BCRX logo
BCRX
BioCryst Pharmaceuticals Inc
2.24B
ZVRA logo
ZVRA
Zevra Therapeutics Inc
665.04M
ESPR logo
ESPR
Esperion Therapeutics Inc
810.91M
best swing trades $10-$20
Intellectia · 209 candidates
Price: $10.00 - $20.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $-5.00 - $15.00Macd: bullish
Ticker
Name
Market Cap$
top bottom
CLBT logo
CLBT
Cellebrite DI Ltd
3.79B
AEVA logo
AEVA
Aeva Technologies Inc
901.80M
SPMC logo
SPMC
Sound Point Meridian Capital Inc
217.22M
NAVN logo
NAVN
Navan Inc
2.58B
GPRE logo
GPRE
Green Plains Inc
1.06B
UMAC logo
UMAC
Unusual Machines Inc
559.45M
what are the best swing trade stocks $10-$20
Intellectia · 33 candidates
Price: $10.00 - $20.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20One Week Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
ARLO logo
ARLO
Arlo Technologies Inc
1.63B
PSKY logo
PSKY
Paramount Skydance Corp
14.83B
STRZ logo
STRZ
Starz Entertainment Corp
189.80M
STUB logo
STUB
StubHub Holdings Inc
3.41B
BRCB logo
BRCB
Black Rock Coffee Bar Inc
690.27M
MOVE logo
MOVE
Movano Inc
14.79M

Whales Holding OMDA

B
BIT Capital GmbH
Holding
OMDA
+20.15%
3M Return
P
Perceptive Advisors LLC
Holding
OMDA
+16.35%
3M Return
D
Divisadero Street Capital Management, LP
Holding
OMDA
+11.38%
3M Return
R
Rock Springs Capital Management LP
Holding
OMDA
+1.39%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Omada Health Inc (OMDA) stock price today?

The current price of OMDA is 14.82 USD — it has decreased -9.63

What is Omada Health Inc (OMDA)'s business?

Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.

What is the price predicton of OMDA Stock?

Wall Street analysts forecast OMDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMDA is27.00 USD with a low forecast of 17.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Omada Health Inc (OMDA)'s revenue for the last quarter?

Omada Health Inc revenue for the last quarter amounts to 69.59M USD, increased 26.62

What is Omada Health Inc (OMDA)'s earnings per share (EPS) for the last quarter?

Omada Health Inc. EPS for the last quarter amounts to -0.05 USD, decreased -70.59

How many employees does Omada Health Inc (OMDA). have?

Omada Health Inc (OMDA) has 916 emplpoyees as of May 09 2026.

What is Omada Health Inc (OMDA) market cap?

Today OMDA has the market capitalization of 880.53M USD.